Harpoon Therapeutics Inc
HARP
Market Cap$865.08M
Close$
$24.80
7.8% upside
Current Fair Value
7.8% upsideUndervalued by 7.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $865.08 Million |
|---|---|
| Enterprise Value | $861.85 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-20.24 |
| Beta | 1.55 |
| Outstanding Shares | 3,947,995 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.14 |
|---|---|
| PEG | 1.34 |
| Price to Sales | 2.56 |
| Price to Book Ratio | 23.01 |
| Enterprise Value to Revenue | 23.08 |
| Enterprise Value to EBIT | -22.98 |
| Enterprise Value to Net Income | -28 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 3.19 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Harpoon Therapeutics Inc
CEO: Gerald McMahon